head and neck

Adaptive radiotherapy and AI in head and neck cancer

Over 12,000 patients are diagnosed with head and neck cancer across the UK every year. Alcohol and tobacco use have long been established as primary risk factors for the development of these cancers. However, there has been a notable increase in the cases of oropharyngeal cancer in recent years, particularly those linked to the oncogenic […]

Polly Darby, John McLellan, Rafael Moleron

Aberdeen Royal Infirmary

Read Article

Development of 3D-printed bolus for head and neck radiotherapy

Radiotherapy bolus refers to tissue-equivalent material placed on the patient’s external surface that alters the dose delivery to superficial areas, such as skin. It is used commonly in head and neck (H&N) treatments, mainly to boost dose to this region and ensure target volumes delineated by clinicians are receiving the desired levels of dose and […]

Rhys Jenkins

South West Wales Cancer Centre, Singleton Hospital

Read Article

Adaptive radiotherapy for head and neck cancer patients

Head and neck (HN) cancer is the eighth most common cancer in the UK. The incidence is around 12,400 new cases every year and the incidence rate has increased by a fifth in the past 10 years. According to Cancer Research UK, between 43% and 85% of those HN cancers have radiotherapy as part of […]

Victor Shing-Cheung Lee

Royal Surrey NHS Foundation Trust

Read Article

Interventional head and neck ultrasound – the Newcastle upon Tyne perspective

There are few sub-specialities in radiology where diagnostic and interventional work are so inextricably linked as head and neck ultrasound, where the operator has fine needle aspiration (FNA) and/or core biopsy at their disposal and tissue sampling offers a valuable extension of the diagnostic scan. This hasn’t always been the case. Around a decade ago […]

Dr Ben Stenberg, Dr Andrew McQueen

Newcastle upon Tyne Hospitals NHS Foundation Trust

Read Article

Arc IMRT for head and neck cancer

Radiotherapy plays an integral role in the treatment of early and locally advanced stage head and neck cancers (HNC). Due to the anatomical location of these tumours and the close proximity to critical structures, the challenge at this tumour site is achieving local control while sparing the organs at risk (OAR), including the spinal cord, […]

Dr Angela Pathmanathan, Dr Teresa Guerrero Urbano

Guy's and St Thomas' Hospital NHS Foundation Trust

Read Article

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.